ISOLATED DNA SEQUENCE, VECTOR, METHOD OF PREPARING HOMOGENEOUS PROTEIN GP 350, HOMOGENEOUS PROTEIN GP 350, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF EBV-MEDIATED DISEASE OR STATE Russian patent published in 2002 - IPC

Abstract RU 2178807 C2

FIELD: biotechnology, genetic engineering, molecular biology. SUBSTANCE: invention proposes the isolated DNA encoding protein gp 350. Protein gp 350 is used in pharmaceutical composition for treatment of EBV-mediated disease or state. Isolated DNA is a component of vector that is inserted in host-cell where expression of protein gp 350 occurs. DNA in vector composition excludes production of protein gp 220 and produces protein gp 350 only. EFFECT: improved method of protein preparing, valuable medicinal properties. 8 cl, 5 dwg, 3 tbl, 4 ex

Similar patents RU2178807C2

Title Year Author Number
MODIFYING EXPRESSION OF FSHβ GENE USING HOMOLOGOUS RECOMBINATION 1999
  • Treko Duglas A.
  • Khartlejn Majkl V.
  • Selden Richard F.
RU2229309C2
DNA CONSTRICT FOR HOMOLOGICAL RECOMBINATION (VARIANTS), TRANSCRIPTION UNIT (VARIANT), METHOD FOR CELL HOMOLOGICAL RECOMBINATION AND METHOD FOR ALTERATION OF TARGET GENE EXPRESSION IN CELL 1995
  • Treko Duglas Eh.
  • Khirtlejn Majkl V.
  • Selden Richard F.
RU2267533C2
VIRUS-ENCODED REGULATED AGENTS BINDING T-CELLS (CATVERT) OR NK-CELLS (CATVERN) TARGETING CANCER 2020
  • Cripe, Timothy, P.
  • Chen, Chun-Yu
  • Hutzen, Brian
  • Currier, Mark
  • Wang, Pin-Yi
  • Chandler, Dawn
RU2827779C2
NEW FUCOSYLTRANSFERASES AND THEIR APPLICATION 2011
  • Parkot Yuliya
  • Khyufner Erik
  • Ennevajn Shtefan
RU2642307C2
ASLV-BASED VECTOR SYSTEM 2010
  • Aksel' Shambakh
  • Kristofer Baum
  • Julija Debora Zjurt
RU2566563C2
RECOMBINANT ANTIBODY, POLYNUCLEOTIDE (VARIANTS), METHOD OF PREPARING HEAVY AND/OR LIGHT CHAINS OF RECOMBINANT ANTIBODY (VARIANTS) 1989
  • Kehri L.Kvin
  • Garol'D Ehdvin Selik
RU2126046C1
NEW FUCOSYLTRANSFERASES AND APPLICATIONS THEREOF 2011
  • Parkot Yuliya
  • Khyufner Erik
  • Ennevajn Shtefan
  • Elling Lotar
  • Engels Leoniya
RU2628307C2
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) 1994
  • Lajmehn Stjuart D.
  • Bekmann M. Patritsija
RU2220979C2
MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE 1995
  • Kehmb Aleksandr
RU2164419C2
MUTATIONS OF MTS GENE IN EMBRYONIC LINE AND METHOD OF DETECTION OF PREDISPOSITION TO MALIGNANT TUMORS 1995
  • Skol'Nik Mark Kh.
  • Kennon-Ehlbrajt Lajza A.
  • Kehmb Aleksandr
RU2161309C2

RU 2 178 807 C2

Authors

Spaet Richard

Dzhekmehn Vintrop T.

Dates

2002-01-27Published

1995-04-13Filed